These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22006830)

  • 1. Comparative structural analysis of α-glucosidase inhibitors on difference species: a computational study.
    Narayana Moorthy NS; Ramos MJ; Fernandes PA
    Arch Pharm (Weinheim); 2012 Apr; 345(4):265-74. PubMed ID: 22006830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of structurally diverse α-glucosidase inhibitors for active site feature analysis.
    Moorthy NS; Ramos MJ; Fernandes PA
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):649-57. PubMed ID: 21899493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorogenic acid derivatives with alkyl chains of different lengths and orientations: potent alpha-glucosidase inhibitors.
    Ma CM; Hattori M; Daneshtalab M; Wang L
    J Med Chem; 2008 Oct; 51(19):6188-94. PubMed ID: 18783210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topological, hydrophobicity, and other descriptors on α-glucosidase inhibition: a QSAR study on xanthone derivatives.
    Moorthy NS; Ramos MJ; Fernandes PA
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):755-66. PubMed ID: 21284409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: a quantitative structure-activity relationship (QSAR) study.
    Moorthy NS; Ramos MJ; Fernandes PA
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):78-87. PubMed ID: 21171896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aglycon specificity profiling of alpha-glucosidases using synthetic probes.
    Hakamata W; Muroi M; Kadokura K; Nishio T; Oku T; Kimura A; Chiba S; Takatsuki A
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1489-92. PubMed ID: 15713413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillusol A, an alpha-glucosidase inhibitor from the marine-derived fungus Aspergillus aculeatus.
    Ingavat N; Dobereiner J; Wiyakrutta S; Mahidol C; Ruchirawat S; Kittakoop P
    J Nat Prod; 2009 Nov; 72(11):2049-52. PubMed ID: 19824618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planar catechin analogues with alkyl side chains: a potent antioxidant and an alpha-glucosidase inhibitor.
    Hakamata W; Nakanishi I; Masuda Y; Shimizu T; Higuchi H; Nakamura Y; Saito S; Urano S; Oku T; Ozawa T; Ikota N; Miyata N; Okuda H; Fukuhara K
    J Am Chem Soc; 2006 May; 128(20):6524-5. PubMed ID: 16704229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.
    Liu Y; Ke Z; Cui J; Chen WH; Ma L; Wang B
    Bioorg Med Chem; 2008 Aug; 16(15):7185-92. PubMed ID: 18632275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the α-glucosidase inhibitory activity of chromenone derivatives based on their molecular features: a computational study.
    Moorthy NS; Ramos MJ; Fernandes PA
    Med Chem; 2011 Nov; 7(6):526-33. PubMed ID: 22313292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel alpha-glucosidase inhibitor from pine bark.
    Kim YM; Wang MH; Rhee HI
    Carbohydr Res; 2004 Feb; 339(3):715-7. PubMed ID: 15013410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for binding feature analysis.
    Moorthy NS; Brás NF; Ramos MJ; Fernandes PA
    Bioorg Med Chem; 2012 Dec; 20(24):6945-59. PubMed ID: 23151473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
    Bharatham K; Bharatham N; Park KH; Lee KW
    J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors.
    Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):777-91. PubMed ID: 21381884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico-based structural analysis of arylthiophene derivatives for FTase inhibitory activity, hERG, and other toxic effects.
    Narayana Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
    J Biomol Screen; 2011 Oct; 16(9):1037-46. PubMed ID: 21821787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship (QSAR) study of a series of benzimidazole derivatives as inhibitors of Saccharomyces cerevisiae.
    Podunavac-Kuzmanović SO; Cvetković DD; Jevrić LR; Uzelac NJ
    Acta Chim Slov; 2013; 60(1):26-33. PubMed ID: 23841329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico based structural analysis of some piperidine analogs as farnesyltransferase inhibitors.
    Moorthy NS; Sousa SF; Ramos MJ; Fernandes PA
    Med Chem; 2012 Sep; 8(5):853-64. PubMed ID: 22741784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of butyl-isobutyl-phthalate and its interaction with α-glucosidase in vitro.
    Liu M; Zhang W; Qiu L; Lin X
    J Biochem; 2011 Jan; 149(1):27-33. PubMed ID: 20870646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.